Professor Anastasios Karadimitris Professor of haematology

Background

Professor Anastasios Karadimitris graduated in medicine at Aristotelion University, Thessaloniki, Greece. He undertook his postgraduate clinical training in the UK, first in general medicine and subsequently in haematology including in bone marrow transplantation at Hammersmith Hospital, London.

He undertook his research training with Professor Lucio Luzzatto at Memorial Sloan Kettering Cancer Centre New York, USA, Professor Irene Roberts at Hammermsith Hospital, London and Professor Vincenzo Cerundolo at the Weatherall Institute for Molecular Medicine, Oxford.

He is currently professor of haematology at the Centre for Haematology, department of medicine, Imperial College, London and honorary consultant haematologist at the department of haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust.

Expertise

Hodgkin and Non-Hodgkin Lymphoma, chronic lymphoproliferative disorders

Research & publications

Prof Karadimitris runs active lab and clinical research programmes in lymphoma and myeloma.

Recent publications:

Iskander D, Psaila B, Gerrard G, et al, 2015, Elucidation of the EP defect in Diamond-Blackfan anemia by characterization and prospective isolation of human EPs, Blood, Vol:125, ISSN:0006-4971, Pages:2553-2557

Johnston AC, Naresh K, Barwick T, et al, 2015, Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma, Annals of Hematology, Vol:94, ISSN:0939-5555, Pages:691-692

Chaidos A, Caputo V, Karadimitris A, 2015, Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence., Ther Adv Hematol, Vol:6, ISSN:2040-6207, Pages:128-141

Ersek A, Xu K, Antonopoulos A, et al, 2015, Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease, Journal of Clinical Investigation, Vol:125, ISSN:0021-9738, Pages:2279-2292

Karadimitris A, Chaidos A, Caputo V, et al, 2015, Myeloma Propagating Cells, Drug Resistance and Relapse., Stem Cells, Vol:33, Pages:3205-3211